Close X
Monday, December 23, 2024
ADVT 
Health

Aging in eye can predict kidney failure risk, finds study

Darpan News Desk IANS, 06 Dec, 2022 01:28 PM
  • Aging in eye can predict kidney failure risk, finds study

Every one-year increase in retinal age has now been linked with a 10 per cent higher risk of incident kidney failure over 11 years of follow-up, a UK study involving 35,864 residents has revealed.

The one-year increase in retinal age was assessed by retinal microvasculature changes, according to the study published in the Peer-reviewed American Journal of Kidney Diseases (AJKD).

"There is a pressing need to identify early predictive biomarkers of kidney failure, given its associated substantial morbidity and mortality. Ageing biomarkers have been associated with kidney failure but their clinical application has been challenging," the researchers reported.

The incidence of end stage kidney disease (ESKD) is known to increase with age.

"We have previously developed and validated retinal age based on fundus images used as a biomarker of ageing. However, the association of retinal age with ESKD is not clear. We investigated the association of the difference between retinal age and chronological age, the retinal age gap, and the future risk of ESKD," said researchers.

In the study, retinal age gap (retina-predicted age minus chronological age), a clinically validated and artificial intelligence powered ageing biomarker based on retinal imaging, was associated with the future risk of kidney failure among UK residents.

This non-invasive and ageing biomarker may hold promise to assist in the identification of people at elevated risk for kidney failure, said the researchers.

Photo courtesy of IStock. 

MORE Health ARTICLES

Third virus vaccine reaches major hurdle: final US testing

Third virus vaccine reaches major hurdle: final US testing
Two other vaccine candidates began final testing this summer in tens of thousands of people in the U.S. One was created by the National Institutes of Health and manufactured by Moderna Inc., and the other developed by Pfizer Inc. and Germany’s BioNTech.

Third virus vaccine reaches major hurdle: final US testing

Surgery backlog could take 84 weeks to clear: study

Surgery backlog could take 84 weeks to clear: study
That directive was lifted in late May and hospitals gradually resumed performing those surgeries.

Surgery backlog could take 84 weeks to clear: study

B.C. hits new daily record with 124 COVID-19 cases

B.C. hits new daily record with 124 COVID-19 cases
Dix and Henry once again encouraged people to keep contact with other people low, particularly at indoor parties and events. "This weekend, let's remember to use the layers of protection that keep ourselves and those around us safe. This is also a good time to think about the new routines that will be part of our activities into the fall," their statement read.

B.C. hits new daily record with 124 COVID-19 cases

Families brace for upheaval as cold and flu season nears

Families brace for upheaval as cold and flu season nears
"Someone's going to get a cold or a cough — probably not COVID, but you're going to be keeping someone home, like, all the time," says Trousdale, whose kids are set to enter grades 1 and 4.

Families brace for upheaval as cold and flu season nears

ER visits down 25 per cent in early 2020: report

ER visits down 25 per cent in early 2020: report
A new report finds emergency department visits dropped by 25 per cent in the early days of the COVID-19 pandemic.

ER visits down 25 per cent in early 2020: report

UN cautions that virus plasma treatment still experimental

UN cautions that virus plasma treatment still experimental
The World Health Organization on Monday cautioned that using blood plasma from COVID-19 survivors to treat other patients is still considered an experimental therapy, voicing the concern as a U.S. boost for the treatment has many scientists afraid formal studies will be derailed.

UN cautions that virus plasma treatment still experimental